gainlogo.png
Gain Therapeutics’ CEO Matthias Alder Issues Letter to Shareholders and Provides Operational Update
31 janv. 2024 08h00 HE | Gain Therapeutics, Inc.
BETHESDA, Md., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain,” or the “Company”), a biotechnology company leading the discovery and development of allosteric small...